Southpoint Capital Advisors LP Fennec Pharmaceuticals Inc. Put Options Transaction History
Southpoint Capital Advisors LP
- $3.57 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FENC
# of Institutions
64Shares Held
14.9MCall Options Held
10KPut Options Held
83.8K-
Sonic Gp LLC Honolulu, HI2.41MShares$11.2 Million27.51% of portfolio
-
Solas Capital Management, LLC Darien, CT1.92MShares$8.93 Million7.68% of portfolio
-
Dg Capital Management, LLC New York, NY1.52MShares$7.06 Million4.41% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$5.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.05MShares$4.86 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $121M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...